Avita Medical | 1811094D - Operating Expenses

Stock Price
1.22
Daily Change
-0.01 -0.41%
Monthly
9.46%
Yearly
-58.81%
Q1 Forecast
1.19

Avita Medical reported AUD29.57M in Operating Expenses for its fiscal semester ending in June of 2025.





Operating Expenses Change Date
Celltrion KRW 724.99B 6B Sep/2025
Clinuvel Pharmaceuticals AUD 20.71M 2.35M Jun/2024
Cochlear AUD 460.1M 437.1M Jun/2025
CSL USD 2.87B 2.85B Jun/2025
Cspc Pharmaceutical CNY 5.4B 298.41M Sep/2025
Dianthus Therapeutics USD 40.68M 5.56M Sep/2025
Divis Laboratories Ltd INR 19.4B 1.47B Sep/2025
Kangmei Pharma CNY 1.39B 144.29M Sep/2025
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Malin Corporation EUR 1.1M 400K Dec/2024
Mayne Pharma AUD 103.54M 9.39M Jun/2024
Medical Developments International AUD 10.02M 9.78M Jun/2025
Nanosonics AUD 47.22M 37.68M Jun/2025
Neuren Pharmaceuticals AUD 8.69M 8.72M Jun/2025
Organigram Holdings CAD 108.11M 17.03M Sep/2025
Pacific Edge NZD 25.34M 2.03M Dec/2025
Paradigm Biopharmaceuticals AUD 8.49M 2.13M Jun/2025
Pharma Mar EUR 39.62M 7.34M Sep/2025
Polynovo AUD 27.51M 19.08M Jun/2024
PYC Therapeutics AUD 19.3M 19.28M Jun/2025
Qiagen NV USD 395.29M 2.28M Sep/2025
Ramsay Health Care AUD 8.72B 369.4M Jun/2025
ResMed USD 922.51M 49.28M Dec/2025
Sartorius EUR 693.1M 29.4M Sep/2025
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Telix Pharmaceuticals AUD 191.9M 130.08M Dec/2024
Tilray USD 237.52M 17.34M Sep/2025
Zz Pientze Pharmaceu CNY 1.55B 129.66M Sep/2025